ID   B2L12_HUMAN             Reviewed;         250 AA.
AC   Q9HB09; A0A087WSV0; Q3SY11; Q3SY13; Q96I96; Q9HB08;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2024, sequence version 2.
DT   18-JUN-2025, entry version 172.
DE   RecName: Full=Bcl-2-like protein 12 {ECO:0000305};
DE            Short=Bcl2-L-12;
DE   AltName: Full=Bcl-2-related proline-rich protein;
GN   Name=BCL2L12 {ECO:0000312|HGNC:HGNC:13787}; Synonyms=BPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=11401436; DOI=10.1006/geno.2000.6455;
RA   Scorilas A., Kyriakopoulou L., Yousef G.M., Ashworth L.K., Kwamie A.,
RA   Diamandis E.P.;
RT   "Molecular cloning, physical mapping, and expression analysis of a novel
RT   gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2
RT   domain of the Bcl-2 family.";
RL   Genomics 72:217-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5] {ECO:0007744|PubMed:18669648}
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; THR-33; SER-37 AND
RP   SER-158, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158 AND SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0007744|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-111; SER-161 AND SER-189, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-60, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- INTERACTION:
CC       Q9HB09; Q07812: BAX; NbExp=3; IntAct=EBI-3940897, EBI-516580;
CC       Q9HB09-1; P0CG48: UBC; NbExp=3; IntAct=EBI-6968951, EBI-3390054;
CC       Q9HB09-2; P08107: HSPA1B; NbExp=2; IntAct=EBI-6969019, EBI-629985;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HB09-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB09-2; Sequence=VSP_000522, VSP_000523;
CC       Name=3;
CC         IsoId=Q9HB09-3; Sequence=VSP_043269;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in breast, thymus, prostate, fetal
CC       liver, colon, placenta, pancreas, small intestine, spinal cord, kidney,
CC       and bone marrow and to a lesser extent in many other tissues. Isoform 2
CC       is primarily expressed in skeletal muscle.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG29495.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAG29496.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH07724.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI04005.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI04006.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI04007.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/773/BCL2L12";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF289220; AAG29495.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF289220; AAG29496.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007724; AAH07724.2; ALT_INIT; mRNA.
DR   EMBL; BC104004; AAI04005.1; ALT_INIT; mRNA.
DR   EMBL; BC104005; AAI04006.1; ALT_INIT; mRNA.
DR   EMBL; BC104006; AAI04007.1; ALT_INIT; mRNA.
DR   CCDS; CCDS12776.2; -. [Q9HB09-1]
DR   CCDS; CCDS46144.2; -. [Q9HB09-3]
DR   CCDS; CCDS92666.1; -. [Q9HB09-2]
DR   RefSeq; NP_001035758.2; NM_001040668.2. [Q9HB09-3]
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   RefSeq; NP_001269446.2; NM_001282517.2. [Q9HB09-2]
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   RefSeq; NP_619580.2; NM_138639.2. [Q9HB09-1]
DR   RefSeq; XP_016882835.1; XM_017027346.1.
DR   AlphaFoldDB; Q9HB09; -.
DR   BioGRID; 123692; 56.
DR   FunCoup; Q9HB09; 552.
DR   IntAct; Q9HB09; 35.
DR   MINT; Q9HB09; -.
DR   STRING; 9606.ENSP00000482218; -.
DR   GlyGen; Q9HB09; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9HB09; -.
DR   PhosphoSitePlus; Q9HB09; -.
DR   SwissPalm; Q9HB09; -.
DR   BioMuta; BCL2L12; -.
DR   DMDM; 23396468; -.
DR   jPOST; Q9HB09; -.
DR   MassIVE; Q9HB09; -.
DR   PaxDb; 9606-ENSP00000482218; -.
DR   PeptideAtlas; Q9HB09; -.
DR   ProteomicsDB; 81467; -. [Q9HB09-1]
DR   ProteomicsDB; 81468; -. [Q9HB09-2]
DR   ProteomicsDB; 81469; -. [Q9HB09-3]
DR   Pumba; Q9HB09; -.
DR   Antibodypedia; 18662; 215 antibodies from 31 providers.
DR   DNASU; 83596; -.
DR   Ensembl; ENST00000246784.8; ENSP00000246784.4; ENSG00000126453.11. [Q9HB09-1]
DR   Ensembl; ENST00000246785.7; ENSP00000246785.3; ENSG00000126453.11. [Q9HB09-1]
DR   Ensembl; ENST00000441864.6; ENSP00000393803.2; ENSG00000126453.11. [Q9HB09-3]
DR   Ensembl; ENST00000594157.5; ENSP00000469216.2; ENSG00000126453.11. [Q9HB09-2]
DR   Ensembl; ENST00000598979.5; ENSP00000471919.2; ENSG00000126453.11. [Q9HB09-2]
DR   Ensembl; ENST00000698560.1; ENSP00000513802.1; ENSG00000126453.11. [Q9HB09-2]
DR   GeneID; 83596; -.
DR   KEGG; hsa:83596; -.
DR   MANE-Select; ENST00000246784.8; ENSP00000246784.4; NM_138639.2; NP_619580.2.
DR   UCSC; uc002ppa.4; human. [Q9HB09-1]
DR   AGR; HGNC:13787; -.
DR   CTD; 83596; -.
DR   DisGeNET; 83596; -.
DR   GeneCards; BCL2L12; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   HPA; ENSG00000126453; Low tissue specificity.
DR   MIM; 610837; gene.
DR   OpenTargets; ENSG00000126453; -.
DR   VEuPathDB; HostDB:ENSG00000126453; -.
DR   eggNOG; ENOG502RYM6; Eukaryota.
DR   GeneTree; ENSGT00940000154318; -.
DR   InParanoid; Q9HB09; -.
DR   OrthoDB; 9948760at2759; -.
DR   PAN-GO; Q9HB09; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q9HB09; -.
DR   PathwayCommons; Q9HB09; -.
DR   SignaLink; Q9HB09; -.
DR   SIGNOR; Q9HB09; -.
DR   BioGRID-ORCS; 83596; 49 hits in 1156 CRISPR screens.
DR   ChiTaRS; BCL2L12; human.
DR   GeneWiki; BCL2L12; -.
DR   GenomeRNAi; 83596; -.
DR   Pharos; Q9HB09; Tbio.
DR   PRO; PR:Q9HB09; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9HB09; protein.
DR   Bgee; ENSG00000126453; Expressed in primordial germ cell in gonad and 132 other cell types or tissues.
DR   ExpressionAtlas; Q9HB09; baseline and differential.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   InterPro; IPR036834; Bcl-2-like_sf.
DR   PANTHER; PTHR14965:SF2; BCL-2-LIKE PROTEIN 12; 1.
DR   PANTHER; PTHR14965; SI:CH73-248E21.1; 1.
DR   SUPFAM; SSF56854; Bcl-2 inhibitors of programmed cell death; 1.
DR   neXtProt; NX_Q9HB09; -.
DR   PharmGKB; PA25306; -.
DR   TreeFam; TF338350; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Methylation; Phosphoprotein;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..250
FT                   /note="Bcl-2-like protein 12"
FT                   /id="PRO_0000143072"
FT   REGION          24..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           227..238
FT                   /note="BH2"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         33
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         60
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         36
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043269"
FT   VAR_SEQ         37..92
FT                   /note="SPAQEEPTDFLSRLRRCLPCSLGRGAAPSESPRPCSLPIRPCYGLEPGPATP
FT                   DFYA -> PSYSRLLCFGGPAAGTAGPRAAEISAQPRITGSPIDREGSHTAEAGGPAGG
FT                   GGRSH (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000522"
FT   VAR_SEQ         93..250
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000523"
FT   CONFLICT        186
FT                   /note="P -> S (in Ref. 3; AAH07724)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   250 AA;  26908 MW;  6349BF6509273664 CRC64;
     MAGSEELGLR EDTLRVLAAF LRRGEAAGSP VPTPPRSPAQ EEPTDFLSRL RRCLPCSLGR
     GAAPSESPRP CSLPIRPCYG LEPGPATPDF YALVAQRLEQ LVQEQLKSPP SPELQGPPST
     EKEAILRRLV ALLEEEAEVI NQKLASDPAL RSKLVRLSSD SFARLVELFC SRDDSSRPSR
     ACPGPPPPSP EPLARLALAM ELSRRVAGLG GTLAGLSVEH VHSFTPWIQA HGGWEGILAV
     SPVDLNLPLD
//
